Goal

Investigational dual GLP-1 / glucagon co-agonist protocol.

Peptides

Survodutide

Why it works

GLP-1-mediated satiety combined with glucagon-driven energy expenditure and hepatic lipid turnover produces additive fat loss.

How to use

  • Survodutide — 0.3 mg weekly sc initial, escalated stepwise every 2-4 weeks to 3.6-4.8 mg weekly.